Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins
- PMID: 7589050
- DOI: 10.1007/BF00198307
Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins
Abstract
The pharmacokinetics of lorazepam was examined in 10 male patients with insulin-dependent diabetes mellitus before and following treatment with neomycin and cholestyramine. Neomycin and cholestyramine were given in an attempt to block the enterohepatic circulation of lorazepam and so to permit an in vivo estimate of hepatic glucuronidation. The volume of distribution and clearance of free lorazepam in diabetic patients were not significantly different from the corresponding estimates in 14 normal controls. Neomycin and cholestyramine increased the clearance of lorazepam by 63% consistent with their effect in non-diabetic controls. However, patients on beef/pork insulin exhibited a greater than normal increase on this interupting regimen (125%), and had a significantly greater neomycin/cholestyramine cycling-interrupted clearance of lorazepam than either normal controls or patients on human insulin (15.4 vs. 6.96 and 7.87 ml.min-1.kg-1). The clearance was correlated positively and significantly with HbA1c and glycated proteins (fructosamine), but only in patients on human insulin. Thus, the pharmacokinetics of lorazepam was not altered in patients with insulin-dependent diabetes mellitus. However, it is possible that there are differences in the rate and extent of hepatic glucuronidation and enterohepatic circulation of lorazepam between patients treated with beef/pork and human insulins and between diabetics treated with beef/pork insulin and non-diabetic controls.
Similar articles
-
Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect.Clin Pharmacol Ther. 1989 Jul;46(1):18-25. doi: 10.1038/clpt.1989.101. Clin Pharmacol Ther. 1989. PMID: 2743706
-
Disposition of lorazepam in Gilbert's syndrome: effects of fasting, feeding, and enterohepatic circulation.J Clin Pharmacol. 1994 Oct;34(10):978-84. doi: 10.1002/j.1552-4604.1994.tb01969.x. J Clin Pharmacol. 1994. PMID: 7836548 Clinical Trial.
-
Multiple-dose lorazepam kinetics: shuttling of lorazepam glucuronide between the circulation and the gut during day- and night-time dosing intervals in response to feeding.J Pharmacol Exp Ther. 1993 Dec;267(3):1034-8. J Pharmacol Exp Ther. 1993. PMID: 8263762
-
Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.Diabetes Technol Ther. 2003;5(1):57-66. doi: 10.1089/152091503763816472. Diabetes Technol Ther. 2003. PMID: 12725708 Review.
-
[The use of human insulin in cases of insulin allergy].Orv Hetil. 1989 May 28;130(22):1159-62. Orv Hetil. 1989. PMID: 2668841 Review. Hungarian.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous